Supplemental Guarantor Financial Information Condensed Consolidating Statement of Cash Flows (Detail) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net earnings (loss) | $6,226 | ($882) |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 22,231 | 22,151 |
Equity-based compensation expense | 4,479 | 4,785 |
Asset Impairment Charges | 4,259 | 0 |
Deferred tax expense (benefit) | 1,173 | -12,614 |
Employee benefit plans | 888 | 2,693 |
Amortization of Financing Costs and Discounts | 475 | 3,544 |
Gain (Loss) on Disposition of Assets | 429 | 0 |
Changes in working capital, net | -5,656 | -9,868 |
Change in taxes receivable, net | 5,523 | 9,547 |
Change in non-current accrued taxes | 19 | -3,177 |
Funding of qualified pension plans | -4,314 | -3,026 |
Other Operating Activities, Cash Flow Statement | -462 | 361 |
Net cash provided by operating activities | 35,270 | 13,514 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Change in short-term investments, net | 11,000 | -65,000 |
Additions to plant and equipment | -16,239 | -19,471 |
Proceeds from Sale of Productive Assets | 460 | 0 |
Net cash used for investing activities | -4,779 | -84,471 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Proceeds from Issuance of Long-term Debt | 0 | 275,000 |
Repayment of Cellu Tissue debt | 0 | -150,000 |
Payments for Repurchase of Common Stock | -29,332 | -50,166 |
Investment (to) from Parent | 0 | 0 |
Payments of Debt Issuance Costs | 0 | -4,723 |
Payment of tax withholdings on equity-based payment arrangements | -792 | -2,195 |
Net cash (used for) provided by financing activities | -30,124 | 67,916 |
Increase in cash | 367 | -3,041 |
Cash at beginning of period | 23,675 | 12,579 |
Cash at end of period | 24,042 | 9,538 |
Issuer | ' | ' |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net earnings (loss) | 5,885 | -37 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 14,121 | 13,784 |
Equity-based compensation expense | 4,479 | 4,785 |
Asset Impairment Charges | 0 | ' |
Deferred tax expense (benefit) | 23,679 | -1,565 |
Employee benefit plans | 888 | 2,693 |
Amortization of Financing Costs and Discounts | 475 | 3,544 |
Gain (Loss) on Disposition of Assets | 139 | ' |
Changes in working capital, net | -1,059 | -6,301 |
Change in taxes receivable, net | -1,965 | 7,181 |
Change in non-current accrued taxes | 10 | -3,183 |
Funding of qualified pension plans | -4,314 | -3,026 |
Other Operating Activities, Cash Flow Statement | -361 | 420 |
Net cash provided by operating activities | 41,977 | 18,295 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Change in short-term investments, net | 11,000 | -65,000 |
Additions to plant and equipment | -12,017 | -16,575 |
Proceeds from Sale of Productive Assets | 4 | ' |
Net cash used for investing activities | -1,013 | -81,575 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Proceeds from Issuance of Long-term Debt | ' | 275,000 |
Repayment of Cellu Tissue debt | ' | -150,000 |
Payments for Repurchase of Common Stock | -29,332 | -50,166 |
Investment (to) from Parent | -7,846 | -8,500 |
Payments of Debt Issuance Costs | ' | -4,723 |
Payment of tax withholdings on equity-based payment arrangements | -792 | -2,195 |
Net cash (used for) provided by financing activities | -37,970 | 59,416 |
Increase in cash | 2,994 | -3,864 |
Cash at beginning of period | 18,273 | 11,105 |
Cash at end of period | 21,267 | 7,241 |
Guarantor Subsidiaries | ' | ' |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net earnings (loss) | -8,485 | -328 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 7,529 | 7,814 |
Equity-based compensation expense | 0 | 0 |
Asset Impairment Charges | 4,259 | ' |
Deferred tax expense (benefit) | -11,492 | -11,700 |
Employee benefit plans | 0 | 0 |
Amortization of Financing Costs and Discounts | 0 | 0 |
Gain (Loss) on Disposition of Assets | 290 | ' |
Changes in working capital, net | -3,062 | -2,629 |
Change in taxes receivable, net | -14,629 | 2,291 |
Change in non-current accrued taxes | 8 | 5 |
Funding of qualified pension plans | 0 | 0 |
Other Operating Activities, Cash Flow Statement | -101 | -59 |
Net cash provided by operating activities | -25,683 | -4,606 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Change in short-term investments, net | 0 | 0 |
Additions to plant and equipment | -4,168 | -2,557 |
Proceeds from Sale of Productive Assets | 456 | ' |
Net cash used for investing activities | -3,712 | -2,557 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Proceeds from Issuance of Long-term Debt | ' | 0 |
Repayment of Cellu Tissue debt | ' | 0 |
Payments for Repurchase of Common Stock | 0 | 0 |
Investment (to) from Parent | 29,395 | 7,160 |
Payments of Debt Issuance Costs | ' | 0 |
Payment of tax withholdings on equity-based payment arrangements | 0 | 0 |
Net cash (used for) provided by financing activities | 29,395 | 7,160 |
Increase in cash | 0 | -3 |
Cash at beginning of period | 0 | 5 |
Cash at end of period | 0 | 2 |
Non-Guarantor Subsidiaries | ' | ' |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net earnings (loss) | -654 | 134 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 581 | 553 |
Equity-based compensation expense | 0 | 0 |
Asset Impairment Charges | 0 | ' |
Deferred tax expense (benefit) | 22 | -707 |
Employee benefit plans | 0 | 0 |
Amortization of Financing Costs and Discounts | 0 | 0 |
Gain (Loss) on Disposition of Assets | 0 | ' |
Changes in working capital, net | -1,535 | -938 |
Change in taxes receivable, net | -79 | -203 |
Change in non-current accrued taxes | 1 | 1 |
Funding of qualified pension plans | 0 | 0 |
Other Operating Activities, Cash Flow Statement | 0 | 0 |
Net cash provided by operating activities | -1,664 | -1,160 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Change in short-term investments, net | 0 | 0 |
Additions to plant and equipment | -54 | -339 |
Proceeds from Sale of Productive Assets | 0 | ' |
Net cash used for investing activities | -54 | -339 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Proceeds from Issuance of Long-term Debt | ' | 0 |
Repayment of Cellu Tissue debt | ' | 0 |
Payments for Repurchase of Common Stock | 0 | 0 |
Investment (to) from Parent | -909 | 2,325 |
Payments of Debt Issuance Costs | ' | 0 |
Payment of tax withholdings on equity-based payment arrangements | 0 | 0 |
Net cash (used for) provided by financing activities | -909 | 2,325 |
Increase in cash | -2,627 | 826 |
Cash at beginning of period | 5,402 | 1,469 |
Cash at end of period | 2,775 | 2,295 |
Eliminations | ' | ' |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net earnings (loss) | 9,480 | -651 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 0 | 0 |
Equity-based compensation expense | 0 | 0 |
Asset Impairment Charges | 0 | ' |
Deferred tax expense (benefit) | -11,036 | 1,358 |
Employee benefit plans | 0 | 0 |
Amortization of Financing Costs and Discounts | 0 | 0 |
Gain (Loss) on Disposition of Assets | 0 | ' |
Changes in working capital, net | 0 | 0 |
Change in taxes receivable, net | 22,196 | 278 |
Change in non-current accrued taxes | 0 | 0 |
Funding of qualified pension plans | 0 | 0 |
Other Operating Activities, Cash Flow Statement | 0 | 0 |
Net cash provided by operating activities | 20,640 | 985 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Change in short-term investments, net | 0 | 0 |
Additions to plant and equipment | 0 | 0 |
Proceeds from Sale of Productive Assets | 0 | ' |
Net cash used for investing activities | 0 | 0 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Proceeds from Issuance of Long-term Debt | ' | 0 |
Repayment of Cellu Tissue debt | ' | 0 |
Payments for Repurchase of Common Stock | 0 | 0 |
Investment (to) from Parent | -20,640 | -985 |
Payments of Debt Issuance Costs | ' | 0 |
Payment of tax withholdings on equity-based payment arrangements | 0 | 0 |
Net cash (used for) provided by financing activities | -20,640 | -985 |
Increase in cash | 0 | 0 |
Cash at beginning of period | 0 | 0 |
Cash at end of period | $0 | $0 |